Pharmaceutical Industry: What You Should Know About the New BCRA Communication “A” 7507 - Ally Latinx

EN

EN ES PT

Richards Cardinal Tützer Zabala Zaefferer
May 9, 2022

Pharmaceutical Industry: What You Should Know About the New BCRA Communication “A” 7507

BCRA broadens exceptions for payment of imports of pharmaceutical products and/or its supplies for local manufacturing. MORE

Share

Related News

Extension of the Regularization Regime for the Presentation of Annual Financial Statements

Stage II of the Federal Concessions Network Activated

Designation of National Competition Authority and Ex-Ante Control